Biomerieux SA (BIOX.PA)

BIOX.PA on Paris Stock Exchange

7:47am EDT
Price Change (% chg)

€0.33 (+0.42%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for BIOX.PA


Biomerieux SA is a France-based company that specializes in the field of in-vitro diagnostics for medical and industrial applications. The Company designs, develops, manufactures and sells systems used in clinical applications, such as for the diagnosis of tuberculosis, respiratory infections, among others and industrial... (more)


Beta: 0.26
Market Cap (Mil.): €3,087.65
Shares Outstanding (Mil.): 39.45
Dividend: 1.00
Yield (%): 1.28


  BIOX.PA Industry Sector
P/E (TTM): 18.81 23.94 33.26
EPS (TTM): 4.16 -- --
ROI: 10.96 11.25 18.95
ROE: 13.61 13.90 19.72
Search Stocks

BioMerieux to look at Siemens microbiology unit: CEO

PARIS - French diagnostics specialist BioMerieux will look at the microbiology unit Siemens is considering selling, BioMerieux's Chief Executive told Reuters.

19 Mar 2014

BioMerieux sees weaker 2014 as forex, investment costs weigh

PARIS, March 19 - French diagnostics specialist company BioMerieux said it expected operating income to drop this year as it deals with adverse exchange rates, the integration of U.S. company BioFire, and ongoing production issues at a U.S. plant.

19 Mar 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Reuters Investment Profile
Provider: MarketLine (a Datamonitor Company)
Provider: GlobalData
Provider: Thomson Reuters StreetEvents
Provider: GlobalData

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks